CME/CE
Jointly provided by the Postgraduate Institute for Medicine and DKBmed, LLC.
Target Audience
This activity has been designed to meet the educational needs of primary care clinicians, including those in traditional clinic settings, urgent care, convenient/retail care, and other settings (eg, emergency department) where health care providers manage patients with migraine.
Activity 1 and 2 Launch: 6/16/23 Activity 1 and 2 Expiration: 6/15/24
Activity 3 Launch: 1/5/24 Activity 3 Expiration: 1/4/25
Educational Objectives
After completing this activity, the participant should be better able to:
Activity 1:- List defining features of migraine.
- Describe the impact of migraine on affected people and the health care system.
- Discuss benefits of newer acute treatment options for people with migraine.
- Describe current and emerging preventive options for migraine.
- List defining features of migraine.
- Describe the burden of migraine.
- Discuss benefits of newer treatments for people with migraine.
- Describe preventive options for migraine.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed, LLC. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Activity 1: The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity 2: The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity 3: The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. Activity 1 is designated for 0.75 AAPA Category 1 CME credits. Activity 2 is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Activity 3 is designated for 0.5 AAPA Category 1 CME credits
Nursing Continuing Professional Development
The Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Activity 1: This 0.75 contact hour Educational Activity is provided by the Postgraduate Institute for Medicine.
Activity 2: This 1.0 contact hour Educational Activity is provided by the Postgraduate Institute for Medicine.
Activity 3: This 0.5 contact hour Educational Activity is provided by the Postgraduate Institute for Medicine.
Media: Internet
Acknowledgement
This activity is supported by an educational grant from Pfizer Inc. and Lundbeck.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Faculty / Presenter Reported Financial Relationship
Anne Damian Yacoub, MD
- None
Michele Soosai, RN, BSN
- None
Planners and Managers
The PIM planners and managers have nothing to disclose. The DKBmed planners and managers have nothing to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Request for Credit
There are no fees for participating and receiving CME/CE credit for this activity.
If you wish to receive acknowledgment for completing this activity, please complete the evaluation.
Contact Information
If you have questions regarding the certification of this activity, please contact PIM via email at [email protected]. For technical issues, please contact [email protected]